Location: Home > Pharma China Web Edition
  • search
  • go
  • Product/R&D News
  • 11/7/2025Lepu to Present Promising Phase II Data of CD20 ADC MRG001 Plus Orelab...
  • 11/7/2025CARsgen Reports Positive Results for Allogeneic CAR-T Therapies CT0596...
  • 11/7/2025Sanofi's Cablivi Wins Approval in China as First Nanobody Therapy for ...
  • 11/7/2025Correctseq Reports World's First Gene-Editing Treatment for Hyperlipid...
  • 11/6/2025China Grants Conditional Approval for ACEA's COVID-19 Antiviral Olgotr...
  • 11/6/2025Novartis Wins China Approval for Two Pluvicto Indications
  • 11/5/2025AbbVie's CD20×CD3 Bispecific Epcoritamab Fails to Win China Approval
  • 11/5/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 11/5/2025CDE Grants Breakthrough Therapy Designation to Ivonescimab for Triple-...
  • 11/4/2025Huadong Medicine Initiates Phase I Trial of CDH17-Targeting ADC HDM201...
  • 11/4/2025CStone Receives NMPA IND Approval for Phase II Trials of CS2009
  • 11/4/2025Abbisko Begins Phase II Trial of Oral PD-L1 Inhibitor ABSK043 in Combo...
  • 11/4/2025Genscript Secures NMPA IND Clearance for Second Bispecific ADC GenSci1...
  • 10/31/2025Lumosa's Stroke Drug Achieves Phase IIb Success in China
  • 10/31/2025Junshi's Toripalimab Becomes First Immunotherapy Approved for NPC in C...
  • 10/31/2025Sichuan Biokin Advances 11th ADC Candidate BL-M24D1 into Clinical Tria...
  • 10/31/2025NMPA Grants Conditional Approval for Lepu Biotech's Becotatug Vedotin
  • 10/29/2025NMPA Approves Huadong Pharma's Mifanertinib Maleate for EGFR-Mutant NS...
  • 10/29/2025Abbisko Presents Promising Preclinical Data on Novel CDK4/2 Inhibitor ...
  • 10/28/2025Metis TechBio to File China NDA for AI-Designed PBA Drug MTS-004
  • 10/28/2025Innovent's Mazdutide Tops Ozempic in Phase III Diabetes and Obesity Tr...
  • 10/27/2025Hengrui's TROP-2 ADC SHR-A1921 Shows Promising Activity in First-in-Hu...
  • 10/27/2025Zai Lab Shares Phase 1 Data for DLL3-Targeted ADC Rivaling Amgen's Imd...
  • 10/27/2025Alphamab Doses First Patient in Phase 1 Trial of PD-L1/αvβ6 Bispecif...
  • 10/27/2025Lanma's LM103 TIL Therapy Moves Into Phase 2 After Promising Phase 1 D...
  • 10/24/2025Chinese Biotech Launches Genos, an Advanced Human-Centric Genomic AI M...
  • 10/24/2025METiS's AI-Designed MTS-004 Becomes China's First AI-Enabled Formulati...
  • 10/24/2025Terns Halts Development of TERN-601 After Phase 2 Results
  • 10/24/2025Boehringer Ingelheim's Jascayd Wins NMPA Approval for IPF
  • 10/22/2025GenScript Wins NMPA IND Nod for Bispecific ADC GenSci139
  • Page:1/20 Total number of articles:596: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group